KaloBios Pharmaceuticals, Inc. (KBIO)


Other OTC - Other OTC Delayed Price. Currency in USD
3.550.00 (0.00%)
As of 3:45 PM EDT. Market open.
People also watch:
CANFPBMDMCURSPHSAEZS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close3.55
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market Cap52.91M
P/E Ratio (ttm)-0.41
Beta3.26
Volume0
Avg Vol (3m)17,617
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 hours ago

    KaloBios CEO to Participate in Pharmaceutical Strategy Conference

    BRISBANE, Calif., Sept. 27, 2016-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, ...

  • Associated Press4 days ago

    KaloBios reports 1Q loss

    The Brisbane, California-based company said it had a loss of $1.22 per share. Losses, adjusted for non-recurring costs, came to 65 cents per share. In the final minutes of trading on Friday, the company's ...

  • Associated Press4 days ago

    KaloBios reports 2Q loss

    On a per-share basis, the Brisbane, California-based company said it had a loss of $2.63. Losses, adjusted for non-recurring costs, were $1.51 per share. In the final minutes of trading on Friday, the ...